Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Uterine Cervical Neoplasms 10Neoplasms 9Breast Neoplasms 9Colorectal Neoplasms 8Lung Neoplasms 5Papillomavirus Infections 3Uterine Cervical Dysplasia 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Heart Diseases 2HIV Infections 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2End Stage Liver Disease 2the Rate of Participation in Screening for PBC 1Warts 1Venous Thromboembolism 1Uterine Cervical Diseases 1Urinary Bladder Neoplasms 1Tinea 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Skin Neoplasms 1Retinoblastoma 1Radiation Injuries 1Pulmonary Atelectasis 1Postural Orthostatic Tachycardia Syndrome 1Postoperative Complications 1

Interventions

Succinylcholine 1Standard of Care 1Saline Solution 1Oxygen 1One-Lung Ventilation 1Mass Screening 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pulmonary Atelectasis × Mass Screening × Clear all
NCT04663958 2026-04-30

Predictive Value of Ariscat Index In The Development of Pulmonary Complication After Major Abdominal Cancer Surgery

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Completed
410 enrolled

Pulmonary Atelectasis, Neoplasms, Pneumonia, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡